These findings suggest that EC-ETAC exerts its anti-obesity effects by modulating the HO-1/Nrf2 pathway, which is crucial for regulating adipogenesis, lipolysis, and adipose browning. The gene discussed is HMOX1; the disease is obesity due to melanocortin 4 receptor deficiency.